PMDA drug package insert
イソプリノシン錠400mg
PMDA Prescription drug · 持田製薬株式会社 · package insert Jun 27, 2023
Key facts
| Brand names | イソプリノシン錠400mg |
|---|---|
| Nonproprietary names | イノシンプラノベクス |
| Companies | 製造販売元／持田製薬株式会社, 提携／ニューポート ファーマシューティカルズ リミテッド |
| Product type | Prescription drug |
| Therapeutic category codes | 87629 |
| YJ codes | 3999007F1031 |
| Approval numbers | 22000AMX01085000 |
| Package insert edition | 第1版 |
| Package insert date | Jun 27, 2023 |
| PMDA document key | 790005_3999007F1031_1 |
| PMDA company code | 790005 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: